#China #Qingdao #Global Sales #Lab Equipment #Haier Biomedical

Haier Biomedical's Leading Position in Global Life Science Lab Equipment

Haier Biomedical has recently garnered significant recognition, being named the top Chinese brand in global sales of life science laboratory equipment by Euromonitor International. This accolade, announced in their 2025 report, not only reflects Haier's strategic expansion but also solidifies its commitment to excellence in the competitive field of laboratory technology.

The achievement marks a dual victory for Haier Biomedical: not only is it first in overall global revenue among Chinese brands, but it also holds the top position in overseas sales. Such a recognition underscores the company's rapid growth and robust market presence, which has exceeded an impressive compound annual growth rate (CAGR) of 20% during its international expansion.

The Path to Success: Three Phases of Expansion

Haier's global outreach began with targeted initiatives in collaboration with reputable organizations such as UNICEF and the World Health Organization. These partnerships focused on addressing urgent needs within communities, particularly emphasizing the solar-powered vaccine storage solutions. Following these initial projects, Haier expanded its network of distributors, now boasting over 800 partners in 160 countries, which significantly enhanced its market reach.

This phased expansion strategy has included the establishment of research and development centers across multiple countries, including the UK, Italy, and Japan. Each facility specializes in specific product lines such as centrifuges, automated storage solutions, incubators, and biosafety cabinets. This geographical diversification not only aids in product development but also strengthens Haier's competitive edge in various regional markets.

Operational Excellence and Product Innovation

In the UK and continental Europe, biotechnology experts focus on supporting compliance with Good Manufacturing Practices (GMP), ensuring the purification of samples and air safety. Consequently, Haier Biomedical has secured its position as a strategic partner in laboratory workflows, reinforcing its reputation within the industry.

Recent data suggests that Haier's sales in Germany, Australia, and Canada surged more than 50% in the first quarter of 2026. Certain regions like Eastern Europe, South Asia, and Brazil experienced even higher growth, doubling the sales volume for essential products such as centrifuges and incubators. Additionally, the company’s Ultra Energy series has dominated the Energy Star rankings in the United States, marking it as the best-selling line in its category.

Forward-Looking Strategies

As Haier Biomedical eyes the future, plans for enhanced localization and an expanded product range are in the pipeline. The company aims to assist bio-pharmaceutical and life science laboratories globally in improving efficiency and sustainability. This goal reflects Haier's vision of leading the supply of integrated tools for life sciences and smart productivity platforms.

Through steadfast dedication to innovation, quality assurance, and strategic partnerships, Haier Biomedical is set to maintain its momentum as a pioneer in the laboratory equipment market, driving advancements that elevate standards across the global healthcare and research sectors.

For further details, you can visit Haier Biomedical's official site.